Lancement de trois produits innovants pour soutenir les tests COVID-19

Paris, France et Camberley, Royaume-Uni – 18 juin 2020 –Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce le lancement de trois nouveaux produits destinés à aider les laboratoires à tester le COVID-19. Il s’agit notamment d’Exsig™ Direct et Exsig™ Mag, deux kits d’extraction d’ARN à utiliser avant d’effectuer un test d’amplification en

Visit Page

Launch of three innovative products to support COVID-19 testing

Paris, France and Camberley, UK – 18 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of three new products to support laboratories testing for COVID-19. These are Exsig™ Direct and Exsig™ Mag, two RNA extraction kits for use prior to running a polymerase chain reaction

Visit Page

Early settlement of term loan and convertible bond facility removes long term debt

Paris, France and Camberley, UK – 3 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it will settle all outstanding debt obligations with Harbert European Growth Capital (“HEGC”) and Vatel Capital SAS (“Vatel”). http://novacyt.com/wp-content/uploads/2020/06/Novacyt-Early-settlement-of-term-loan-03-06-20-ENGLISH.pdf

Visit Page